The GSC’s Gregg Morin Lab, with Drs. Torsten Nielson and Stephen Chia, identify new breast cancer subtypes linked to patient outcomes using proteomic analysis on archival clinical tissue samples.
The GSC’s Gregg Morin Lab characterizes the mechanism of action of a novel small molecule inhibitor and demonstrates its therapeutic potential in lung cancer cells.
A new animated video that explains cancer genomics in simple language and relatable graphics is useful for many audiences including patients that may want to participate in the program, researchers and practitioners working in the field and those helping to educate others on the topic.
Researchers from the Karsan Lab at the GSC implicate immune-related proteins TIRAP, IFNγ, and Hmgb1 in preleukemic syndrome development and elucidate protein interplay.